Jump to navigation
Read IPM's latest annual report to learn about progress on our innovative pipeline of long-acting, self-initiated HIV prevention products for women.
IPM’s monthly dapivirine ring is the first microbicide shown to safely help prevent HIV infection in women in two large efficacy trials. Learn more about what’s next for this innovative product.
MSN looks at what the latest data on IPM's dapivirine ring could mean for women at risk for HIV.
Find out how investing in innovative tools to promote women’s sexual and reproductive health is an investment for sustainable development.
Watch our “Real Voices” videos to hear people working to prevent HIV describe their hopes for how microbicides could help protect women in their communities.